Autoimmune Diseases  >>  BMS-582949  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-582949 / BMS
NCT00605735 / 2008-000170-20: PoC in Rheumatoid Arthritis With Methotrexate

Completed
2
121
US, Europe, RoW
BMS-582949, P38 Inflamation, Placebo
Bristol-Myers Squibb
Rheumatoid Arthritis, NOS
08/09
09/09

Download Options